Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Jordan K Schaefer, MD, Josh Errickson, PhD, Xiaokui Gu, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 788.

https://doi.org/10.1182/blood-2019-123067

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

Chronic Kidney Disease (CKD) in the U.S. Hemophilia Population: A Cohort Study

Blood (2018) 132 (Supplement 1): 2479.

https://doi.org/10.1182/blood-2018-99-119637

Published: 2018

Journal Articles

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Jordan K. Schaefer, MD, Zhenke Wu, PhD, Mengbing Li, Jennifer J Griggs, MD MPH, Suman L. Sood, MD

Blood (2018) 132 (Supplement 1): 2225.

https://doi.org/10.1182/blood-2018-99-117931

Published: 2018

Journal Articles

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

Fares Alsawah, MD BS, MS, Samuel A. Merrill, MD PhD, Paula L. Bockenstedt, MD, Erica L. Campagnaro, MD, Sumana Devata, MD, Scott D. Gitlin, MD, Mark S Kaminski, MD, Alice M. Cusick, MD, Tycel J. Phillips, MD, Suman L. Sood, MD, Moshe Talpaz, MD, Albert Thomas Quiery, MD, Philip S Boonstra, PhD, Asra Z. Ahmed, MD, Ryan A. Wilcox, MD PhD

Blood (2018) 132 (Supplement 1): 1119.

https://doi.org/10.1182/blood-2018-99-116854

Published: 2018

Journal Articles

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2017) 130 (Supplement 1): 220.

https://doi.org/10.1182/blood.V130.Suppl_1.220.220

Published: 2017

Journal Articles

Chronic Kidney Disease in the U.S. Hemophilia Population: A Cohort Study

Blood (2017) 130 (Supplement 1): 2359.

https://doi.org/10.1182/blood.V130.Suppl_1.2359.2359

Published: 2017

Journal Articles

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

Jordan K. Schaefer, MD, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2016) 128 (22): 1179.

https://doi.org/10.1182/blood.V128.22.1179.1179

Published: 2016

Journal Articles

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score

Dana E. Angelini, MD, M. Todd Greene, PhD MPH, Julie N Wietzke, MHSA, MLS, Scott A Flanders, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 1181.

https://doi.org/10.1182/blood.V128.22.1181.1181

Published: 2016

Journal Articles

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Dana E. Angelini, MD, Sumana Devata, MD, Angela E. Hawley, Susan A. Blackburn, RN, MBA, Satwinder Grewal, Martina V Hemmer, MA, Henry Flanner, MS, William Kramer, PhD, William E Parker, Yu-Ling Li, MS, MD, Daniel Durant Myers, DVM, MPH, James B. Froehlich, MD MPH, John L Magnani, PhD, Helen M. Thackray, MD, Thomas W. Wakefield, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 3826.

https://doi.org/10.1182/blood.V128.22.3826.3826

Published: 2016

Journal Articles

Biomarkers and Clinical Prediction Rules in the Diagnosis of Suspected Deep Vein Thrombosis: A Comparison of Cancer and Non-Cancer Patients

Jordan K. Schaefer, MD, Dana E. Angelini, MD, Angela Hawley, MS, Susan A. Blackburn, RN, MBA, Elizabeth Lusk, Thomas M. Braun, PhD, Thomas W. Wakefield, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 3804.

https://doi.org/10.1182/blood.V128.22.3804.3804

Published: 2016

Journal Articles

First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile

Sumana Devata, MD, Suman L. Sood, MD, Martina V Hemmer, MA, Henry Flanner, MS, William Kramer, PhD, Christine Nietubicz, Angela Hawley, Dana E Angelini, MD, Daniel Durant Myers, DVM, MPH, Susan Blackburn, James Froehlich, MD, Thomas W. Wakefield, MD, John L. Magnani, PhD, Helen M. Thackray, MD

Blood (2015) 126 (23): 1004.

https://doi.org/10.1182/blood.V126.23.1004.1004

Published: 2015

Journal Articles

Defining the Risk: Benefit Ratio of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Cancer Patients

Dana E Angelini, MD, Todd Greene, PhD MPH, Julie N Wietzke, MHSA, MLS, Scott A Flanders, MD, Suman L. Sood, MD

Blood (2015) 126 (23): 627.

https://doi.org/10.1182/blood.V126.23.627.627

Published: 2015

Journal Articles

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

Blood (2015) 126 (23): 761.

https://doi.org/10.1182/blood.V126.23.761.761

Published: 2015

Journal Articles

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

Blood (2014) 124 (21): 2836.

https://doi.org/10.1182/blood.V124.21.2836.2836

Published: 2014

Journal Articles

Soluble P-Selectin and Age Adjusted D-Dimer As Predictive Biomarkers of Venous Thrombosis

Dana E Angelini, MD, Cathy Stabler, R.N., Angela E. Hawley, Kenneth E. Guire, M.S., Daniel Durant Myers, DVM,MPH, Susan Blackburn, R.N., Thomas W. Wakefield, MD, Suman L. Sood, MD

Blood (2014) 124 (21): 2863.

https://doi.org/10.1182/blood.V124.21.2863.2863

Published: 2014

Journal Articles

E-Selectin Inhibitor GMI-1271 Works in Combination with Low-Molecular Weight Heparin to Decrease Venous Thrombosis and Bleeding Risk in a Mouse Model

Daniel Durant Myers, DVM,MPH, Shirely K. Wrobleski, BS, Krus Kelsey, Diana Farris, Diaz A. Jose, MD, Henke K. Peter, MD, Suman L. Sood, MD, Thomas W. Wakefield, MD, John L. Magnani, PhD

Blood (2014) 124 (21): 593.

https://doi.org/10.1182/blood.V124.21.593.593

Published: 2014

Journal Articles

Biomarkers and Clinical Characteristics Of Patients With and Without DVT In The Intensive Care Unit (ICU)

Suman L. Sood, MD, Cathy Stabler, R.N., Angela E. Hawley, MS, Kenneth E. Guire, M.S., Susan Blackburn, R.N., Molly Oberdoerster, B.A., Mariam Khan, Jose A. Diaz, MD, Thomas W. Wakefield, MD

Blood (2013) 122 (21): 1124.

https://doi.org/10.1182/blood.V122.21.1124.1124

Published: 2013

Journal Articles

Prediction of Venous Thromboembolism (VTE) in Patients with Pancreatic Cancer Using Clinical Data, Biomarkers, and VTE Risk Models

Joshua M Ruch, MD, Emily Bellile, MS, Angela E. Hawley, MS, Michelle A. Anderson, MD, Thomas W. Wakefield, MD, Suman L. Sood, MD

Blood (2012) 120 (21): 3398.

https://doi.org/10.1182/blood.V120.21.3398.3398

Published: 2012

Journal Articles

Soluble P-Selectin for the Diagnosis of Deep Vein Thrombosis (DVT) in Cancer Patients

Suman L. Sood, MD, Cathy Stabler, R.N., Mariam Khan, Angela E. Hawley, Kenneth E. Guire, M.S., Thomas W. Wakefield, MD

Blood (2012) 120 (21): 3406.

https://doi.org/10.1182/blood.V120.21.3406.3406

Published: 2012

NARROW

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Chronic Kidney Disease (CKD) in the U.S. Hemophilia Population: A Cohort Study

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Chronic Kidney Disease in the U.S. Hemophilia Population: A Cohort Study

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Biomarkers and Clinical Prediction Rules in the Diagnosis of Suspected Deep Vein Thrombosis: A Comparison of Cancer and Non-Cancer Patients

First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile

Defining the Risk: Benefit Ratio of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Cancer Patients

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

Soluble P-Selectin and Age Adjusted D-Dimer As Predictive Biomarkers of Venous Thrombosis

E-Selectin Inhibitor GMI-1271 Works in Combination with Low-Molecular Weight Heparin to Decrease Venous Thrombosis and Bleeding Risk in a Mouse Model

Biomarkers and Clinical Characteristics Of Patients With and Without DVT In The Intensive Care Unit (ICU)

Prediction of Venous Thromboembolism (VTE) in Patients with Pancreatic Cancer Using Clinical Data, Biomarkers, and VTE Risk Models

Soluble P-Selectin for the Diagnosis of Deep Vein Thrombosis (DVT) in Cancer Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only